Cargando…

O8.2. VALIDATION OF A COMPUTERIZED ADAPTIVE TESTING TOOL FOR PSYCHOSIS: THE CAT-PSYCHOSIS BATTERY

BACKGROUND: Time constraints limit the use of measurement-based approaches in the routine clinical management of schizophrenia. Computerized Adaptive Testing (CAT) uses computational algorithms (item response theory - IRT) to match individual subjects with only the most relevant questions for them,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guinart, Daniel, de Filippis, Renato, Rosson, Stella, Prizgint, Lara, Patil, Bhagyashree, Talasazan, Nahal, Gibbons, Robert D, Kane, John M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Oral Session: Digital Health/Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233957/ http://dx.doi.org/10.1093/schbul/sbaa028.043

Ejemplares similares

O5.2. CBD MODULATION OF HIPPOCAMPAL GLUTAMATE IN PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2020)

O5.4. THALAMIC CONNECTIVITY IN EARLY PSYCHOSIS DURING TASK AND AT REST
por: Berge, Daniel, et al.
Publicado: (2020)

O8.3. DEVELOPMENT AND UTILITY OF THE MAUDSLEY ENVIRONMENTAL RISK SCORE FOR PSYCHOSIS
Publicado: (2020)

O10.6. ANTERIOR VERSUS POSTERIOR HIPPOCAMPUS WITHIN PSYCHOSIS: A BSNIP STUDY
por: del Re, Elisabetta C, et al.
Publicado: (2020)

O1.2. REDUCING THE DURATION OF UNTREATED PSYCHOSIS IN A U.S. CATCHMENT: THE MINDMAP CAMPAIGN
por: Srihari, Vinod, et al.
Publicado: (2020)

O2.3. ABNORMAL BRAIN AGING IN YOUTH WITH SUBCLINICAL PSYCHOSIS AND OBSESSIVE-COMPULSIVE SYMPTOMS
por: Cropley, Vanessa, et al.
Publicado: (2020)

O4.5. LONG TERM EFFECTS OF EARLY INTERVENTION SERVICES FOR FIRST EPISODE PSYCHOSIS: OUTCOMES OVER FIVE YEARS FROM THE RECOVERY AFTER A 1ST EPISODE OF SCHIZOPHRENIA-EARLY TREATMENT PROGRAM (RAISE-ETP)
por: Robinson, Delbert, et al.
Publicado: (2020)

O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS
por: Clementz, Brett, et al.
Publicado: (2020)

O6.6. MULTIMODAL PROGNOSIS OF NEGATIVE SYMPTOM SEVERITY IN INDIVIDUALS WITH INCREASED RISK OF DEVELOPING PSYCHOSIS
por: Hauke, Daniel, et al.
Publicado: (2020)

O10.4. THE ROLE OF CONTEXTUAL FACTORS AND ASSESSMENT STRATEGIES IN THE ACCURATE SCREENING OF PSYCHOSIS-RISK SYMPTOMS
por: Schiffman, Jason, et al.
Publicado: (2020)

O9.3. CANNABIS CONSUMPTION INCREASES RISK OF PSYCHOSIS IN A SUBGROUP OF PATIENTS WITH HIGH PERIPHERAL BLOOD INFLAMMATION
por: Corsi-Zuelli, Fabiana, et al.
Publicado: (2020)

O2.5. CORTICAL PATTERNING OF ABNORMAL MORPHOMETRIC SIMILARITY IN PSYCHOSIS IS ASSOCIATED WITH BRAIN EXPRESSION OF SCHIZOPHRENIA-RELATED GENES
Publicado: (2020)

O6.1. COGNITIVE CONTROL DIFFERENCES BETWEEN TREATMENT RESPONSIVE AND TREATMENT RESISTANT FIRST-EPISODE PSYCHOSIS PATIENTS
Publicado: (2020)

O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT
por: Di Biase, Maria, et al.
Publicado: (2020)

O5.3. IMPAIRED LEFT TEMPORAL-PARIETAL JUNCTION FMRI ACTIVITY DURING CATEGORY FLUENCY IN FIRST-EPISODE PSYCHOSIS
por: Perumaly, Leana, et al.
Publicado: (2020)

O3.5. EARLY TRAJECTORIES OF POSITIVE SYMPTOMS REMISSION IN FIRST EPISODE-PSYCHOSIS: A 2-YEAR FOLLOW-UP STUDY
por: Percie du Sert, Olivier, et al.
Publicado: (2020)

O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)

O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY
por: Hamilton, Holly, et al.
Publicado: (2020)

O1.3. BACK TO THE FUTURE: PREDICTING POPULATION NEED FOR PSYCHOSIS CARE BASED ON THE EPIDEMIOLOGY OF PSYCHOTIC DISORDERS IN ENGLAND, AN APPLIED BAYESIAN METHODOLOGY
por: McDonald, Keltie, et al.
Publicado: (2020)

O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
por: Schultze-Lutter, Frauke, et al.
Publicado: (2020)

O10.1. MATERNAL PRENATAL C-REACTIVE PROTEIN, NEURODEVELOPMENT AND OTHER RISK FACTORS FOR PSYCHOSIS IN ADOLESCENT OFFSPRING IN THE NORTHERN FINLAND BIRTH COHORT 1986
por: Ramsay, Hugh, et al.
Publicado: (2020)

O6.4. ASSOCIATION BETWEEN CLUSTERS OF FORMAL THOUGHT DISORDERS SEVERITY AND NEUROCOGNITIVE AND FUNCTIONAL OUTCOME INDICES IN THE EARLY STAGES OF PSYCHOSIS – RESULTS FROM THE PRONIA COHORT
por: Öztürk, Ömer Faruk, et al.
Publicado: (2020)

Computerized Assessment of Psychosis Risk
por: Mittal, Vijay A., et al.
Publicado: (2021)

M82. GROWING BURDEN OF DISEASE: THE PREVALENCE OF CHRONIC HEALTH CONDITIONS AFTER A FIRST EPISODE OF PSYCHOSIS
por: Rodrigues, Myanca, et al.
Publicado: (2020)

T230. IDENTITY IN THE EARLY STAGES OF PSYCHOSIS: PERSPECTIVES OF CANADIAN EARLY PSYCHOSIS CLINICIANS
por: Ben-David, Shelly, et al.
Publicado: (2020)

M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chi Yiu Wong, Sandra, et al.
Publicado: (2020)

S163. GLUTAMATERGIC METABOLITES IN THE PSYCHOSIS SPECTRUM: FROM HIGH RISK SAMPLES TO FIRST EPISODE PSYCHOSIS
por: Fortea, Adriana, et al.
Publicado: (2020)

M118. FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
por: Lee, Kyuyoung, et al.
Publicado: (2020)

T85. LIVING WITH PSYCHOSIS IN LATER LIFE
por: Galletly, Cherrie, et al.
Publicado: (2020)

What are the physical and mental health implications of duration of untreated psychosis?
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Telemental Health and the Management of Psychosis
por: Donahue, Amy L., et al.
Publicado: (2021)

S103. ASSESSING MOOD SYMPTOMS IN PSYCHOSIS: EXAMINING DIFFERENCES IN MOOD SYMPTOM PRESENTATION AMONGST RACIAL AND ETHNIC MINORITIES WITH PSYCHOSIS
por: Bolden, Khalima, et al.
Publicado: (2020)

T23. ANTIPSYCHOTIC EXPOSURE AND STRIATAL FUNCTIONAL CONNECTIVITY IN PSYCHOSIS RELAPSE: A HYPOTHESIS GENERATING STUDY
por: Rubio, Jose, et al.
Publicado: (2020)

S53. DELINEATING SOCIAL COGNITION IN AUTISM AND PSYCHOSIS
por: Ziermans, Tim, et al.
Publicado: (2020)

S123. EARLY DETECTION OF PSYCHOSIS: DIAGNOSTIC TRAJECTORIES
por: Lindhardt, Line, et al.
Publicado: (2020)

O4.2. THE PREVENTION OF RELAPSE AND HOSPITALIZATION IN FIRST EPISODE AND EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE PRELAPSE TRIAL
por: Kane, John, et al.
Publicado: (2020)

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

M169. HIPPOCAMPAL GLUTAMATE AND HIPPOCAMPUS SUBFIELD VOLUMES IN ANTIPSYCHOTIC-NAIVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS
Publicado: (2020)

M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2020)

T237. PERSON-CENTERED PSYCHOSIS CARE –HOW INCREASING PERSON-CENTEREDNESS IN PSYCHOSIS INPATIENT CARE RELATE TO CARE CONSUMPTION AND WARD BURDEN
por: Allerby, Katarina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d4kt8bep9ie3frrsbh528qnjn6